Search results for “Growth hormone-releasing peptide” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 233 patents, we discovered top 47 key players by total patent application. Ipsen Pharma SAS, Tulane Educational Fund, Pfizer Inc. are dominant in this area. They take 25.75% of the total patent filing.
Ipsen Pharma SAS
France
Patent: 21
Tulane Educational Fund
Louisiana, United States
Patent: 21
Pfizer Inc.
New York, United States
Patent: 18
Centro de Ingenieria Genetica y Biotecnologia
HAVANA, Cuba
Patent: 17
Ocera Therapeutics, Inc.
California, United States
Patent: 16
Genentech, Inc.
California, United States
Patent: 12
Helsinn Healthcare SA
Ticino, Switzerland
Patent: 11
Helsinn Therapeutics (U.S.), Inc.
New Jersey, United States
Patent: 11
Tranzyme Pharma, Inc.
Canada
Patent: 8
RaQualia Pharma, Inc.
Aichi-ken, Japan
Patent: 6
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 2 patents, we discovered top 1 start-ups by total patent application.
STARTUP
AnaCardio AB
STOCKHOLM, Sweden
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 23 patents applied in the last 5 years. We discover 11 most active companies in this area. The fast-growing Centro de Ingenieria Genetica y Biotecnologia, Helsinn Healthcare SA, Helsinn Advanced Synthesis SA take 78.26% of patent filing during this period.
Centro de Ingenieria Genetica y Biotecnologia
HAVANA, Cuba
Patent: 12
Helsinn Healthcare SA
Ticino, Switzerland
Patent: 4
Helsinn Advanced Synthesis SA
Switzerland
Patent: 2
Helsinn Therapeutics (U.S.), Inc.
New Jersey, United States
Patent: 2
Kazusa Dna Research Institute
Japan
Patent: 1
STARTUP
AnaCardio AB
STOCKHOLM, Sweden
Patent: 1
Shanghai Tuojie Biotechnology Co., Ltd.
Shanghai Shi, China
Patent: 1
Ipsen Pharma SAS
France
Patent: 1
Kyoto University
Kyoto-fu, Japan
Patent: 1
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 23 patents in last 5 years, we discover 6 new entrants. Helsinn Advanced Synthesis SA, Kazusa Dna Research Institute, AnaCardio AB are the most active new entrants in this area.
Helsinn Advanced Synthesis SA
Switzerland
Patent: 2
Kazusa Dna Research Institute
Japan
Patent: 1
STARTUP
AnaCardio AB
STOCKHOLM, Sweden
Patent: 1
Shanghai Tuojie Biotechnology Co., Ltd.
Shanghai Shi, China
Patent: 1
Kyoto University
Kyoto-fu, Japan
Patent: 1
Glaxosmithkline Intellectual Property Development Ltd.
East Sussex, United Kingdom
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 17 patents, we discovered top 6 universities and scientific research institutions by total patent application. The Scripps Research Institute, Queensland University of Technology, McGill University are dominant in this area. They take 64.71% of the total patent filing.
The Scripps Research Institute
California, United States
Patent: 5
Queensland University of Technology
Queensland, Australia
Patent: 2
McGill University
Ontario, Canada
Patent: 1
Kyoto University
Kyoto-fu, Japan
Patent: 1
Keio University
Tokyo-to, Japan
Patent: 1
The Salk Institute for Biological Studies
California, United States
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: